venBio Global Strategic GP II, L.P., 10% Owner at Checkmate Pharmaceuticals, Inc. (CMPI), sold 259,562 shares at $10.38 ($2.7M) on 2022-04-26, disclosed to the SEC on 2022-04-26.
Open-market sale of $2.7M CMPI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.39 | 37,430 | $389K | 14.4% |
| 2 | $10.39 | 37,430 | $389K | 14.4% |
| 3 | $10.39 | 27,668 | $287K | 10.7% |
| 4 | $10.39 | 27,668 | $287K | 10.7% |
| 5 | $10.38 | 64,683 | $671K | 24.9% |
| 6 | $10.38 | 64,683 |
| $671K |
| 24.9% |
| Total | $10.39 avg | 259,562 | $2.7M | 100% |
| Filing → |